Detalhe da pesquisa
1.
USP17 is required for trafficking and oncogenic signaling of mutant EGFR in NSCLC cells.
Cell Commun Signal;
16(1): 77, 2018 11 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30409180
2.
Enhanced target-specific delivery of docetaxel-loaded nanoparticles using engineered T cell receptors.
Nanoscale;
13(35): 15010-15020, 2021 Sep 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34533174
3.
Refined construction of antibody-targeted nanoparticles leads to superior antigen binding and enhanced delivery of an entrapped payload to pancreatic cancer cells.
Nanoscale;
12(21): 11647-11658, 2020 Jun 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32436550
4.
DR5-targeted, chemotherapeutic drug-loaded nanoparticles induce apoptosis and tumor regression in pancreatic cancer in vivo models.
J Control Release;
324: 610-619, 2020 08 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32504778
5.
Repurposing of Cetuximab in antibody-directed chemotherapy-loaded nanoparticles in EGFR therapy-resistant pancreatic tumours.
Nanoscale;
11(42): 20261-20273, 2019 Nov 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31626255
6.
Single-Domain Antibody-Functionalized pH-Responsive Amphiphilic Block Copolymer Nanoparticles for Epidermal Growth Factor Receptor Targeted Cancer Therapy.
ACS Macro Lett;
7(8): 1010-1015, 2018 Aug 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35650954